Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction

The Journal of Clinical Investigation
K A NathT H Hostetter

Abstract

Dietary protein restriction imposed before renal injury is established in the remnant kidney model in the rat reduces glomerular hypertension and hyperperfusion and renal injury. We demonstrate that dietary protein restriction (6% vs. 20%) imposed on a background of established renal injury in the remnant model leads to a greater preservation of renal function as measured by glomerular filtration rate and fractional clearances of albumin and IgG, despite the persistence of systemic hypertension. In similarly prepared rats, dietary protein restriction (6% vs. 20%) led to a lower glomerular capillary hydraulic pressure, a higher ultrafiltration coefficient, and similar single nephron filtration rates. In addition, less impairment of glomerular permselectivity was demonstrable after protein restriction. Our data demonstrate that the preservation of renal function with dietary protein restriction after established glomerular injury follows upon reduction of glomerular capillary hydraulic pressure, despite constancy of single nephron filtration rate and plasma flow and persistence of arterial hypertension.

References

May 1, 1979·Kidney International·C KleinknechtM C Gubler
Sep 1, 1979·Kidney International·W M DeenB M Brenner
May 1, 1976·Kidney International·M L PurkersonS Klahr
Aug 1, 1985·The Journal of Clinical Investigation·S AndersonB M Brenner
Aug 1, 1985·Kidney International·C Baylis, H G Rennke
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M L PurkersonS Klahr
Jun 1, 1973·The Journal of Clinical Investigation·W M DeenB M Brenner
Jan 1, 1966·Pflügers Archiv für die gesamte Physiologie des Menschen und der Tiere·K H GertzH D Pagel
Oct 1, 1982·The Journal of Clinical Investigation·B D MyersW M Deen
Nov 1, 1983·Kidney International·S KlahrM L Purkerson
Jan 1, 1984·Annual Review of Medicine·W E Mitch
Dec 1, 1983·The American Journal of Medicine·J P BoschS Glabman
Nov 1, 1983·Kidney International·J NeugartenD S Baldwin
May 1, 1984·The Journal of Clinical Investigation·L D DworkinB M Brenner
May 1, 1980·The Journal of Clinical Investigation·I IchikawaB M Brenner

❮ Previous
Next ❯

Citations

Mar 1, 1991·Diabetes/metabolism Reviews·G PuglieseJ R Williamson
Jan 1, 1993·Contributions to Nephrology·R D Lindeman
Sep 1, 1989·Klinische Wochenschrift·A M el Nahas
Feb 1, 1990·Cardiovascular Drugs and Therapy·J A OpsahlW F Keane
Jan 1, 1992·European Journal of Clinical Pharmacology·E BrändleH G Sieberth
Jul 25, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Agnes B Fogo
Jul 1, 2008·Indian Journal of Clinical Biochemistry : IJCB·R B BhogadeR Y Patil
Oct 5, 1988·The American Journal of Cardiology·J P TolinsL Raij
Jun 27, 2007·Nature Clinical Practice. Nephrology·Denis Fouque, Michel Aparicio
Jun 26, 2002·Kidney International·Henrik Post HansenHans-Henrik Parving
Apr 22, 2003·Seminars in Nephrology·Agnes B Fogo
Feb 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Conall M O'SeaghdhaCaroline S Fox
Jun 3, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hye Won ParkMichael Mauer
Mar 18, 1999·Transplant International : Official Journal of the European Society for Organ Transplantation·A BombasP Jablonski
Dec 1, 1993·Archives of Disease in Childhood·J T Brocklebank, S Wolfe
Jul 7, 2009·Annual Review of Nutrition·Harold A Franch, William E Mitch
Apr 1, 1990·The Journal of Clinical Investigation·P L MillerT W Meyer
Apr 1, 1990·The Journal of Clinical Investigation·M E RosenbergT H Hostetter
Oct 1, 1990·The Journal of Clinical Investigation·K A Nath, A K Salahudeen
Jul 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J R Neuringer, B M Brenner
Mar 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J D CongerD M Gillum
Feb 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S A FalkJ D Conger
Mar 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A RemuzziG Remuzzi
Mar 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M PragaJ L Rodicio
Mar 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L G FineC Gallego
Feb 27, 2013·Advances in Chronic Kidney Disease·Jerry Yee
Jun 1, 1996·Kidney International·B M BrennerH S Mackenzie
Nov 1, 1988·Kidney International·I IchikawaS Klahr
Dec 1, 1988·Kidney International·M Walser, L Ward
Feb 1, 1990·Kidney International·C A Miskell, D P Simpson
Aug 1, 1990·Kidney International·M E RosenbergT H Hostetter
Jan 1, 1992·Kidney International·A K SalahudeenM E Rosenberg
Mar 29, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·T SakemiT Uesugi
Jan 6, 2009·Seminars in Nephrology·Denis Fouque, Fitsum Guebre-Egziabher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.